This Solicitation opportunity from Department Of Defense was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

GUAIFENESIN EXTENDE

Closed

SPE2DP-26-T-3451Federal

Submission Closed05/26/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supply of Bupivacaine Hydrochloride InjectionThis subcontract involves the supply of pharmaceutical-grade Bupivacaine Hydrochloride Injection, USP, 0.5%, 50 ML (NSN: 6505001387347) to prime contractors supporting Department of Defense DLA Troop Support medical supply contracts. The agreement requires the delivery of 2,000 units within a strict five-day window, ensuring all products meet USP standards and possess a minimum shelf-life of 24 months. To maintain product integrity, the supplier must utilize climate-controlled logistics to keep the injections within a temperature range of 20 to 25 degrees Celsius. This procurement is managed under NAICS code 325412 through the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ARTIFICIAL TEARS SOLUT

Solicitation # SPE2DP-27-T-0204

Solicitation SPE2DP-27-T-0204 is a small business set-aside issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of 40 bottles of 1.4% artificial tears solution (NSN 6505009617486), each with a 15 ML capacity. The contract requires a non-extendable shelf life of 36 months and specifies delivery to the USS NITZE DDG 94. Delivery is required within 20 days after receipt of order, with an original required delivery date of October 28, 2026. The terms are FOB Destination, and both inspection and acceptance will occur at the destination. The contractor must adhere to strict packaging and marking standards, primarily Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial and sealed in suitable containers to prevent damage, with palletization following DLA requirement RP001. If the material is deemed hazardous per FED-STD-313, it must be packaged according to TQ requirement IP025 and labeled per the Hazard Communication Standard; otherwise, ASTM D3951 applies. Invoicing must be processed electronically through the Wide Area WorkFlow system. The award process includes a HUBZone price evaluation preference, and any offers utilizing additive manufacturing are ineligible for award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PERMETHRIN CREAM RINSE

Solicitation # SPE2DP-27-T-0202

This solicitation, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of six units of Permethrin Cream Rinse (NSN 6505-01-256-4972). The required product is a 1% W/V Permethrin active ingredient supplied in a 2 fl oz plastic squeeze bottle and must include a comb. The item is FDA-regulated and has a total shelf life of 24 months, with a mandatory minimum of 21 months remaining upon receipt by the government. Delivery is required within five days after receipt of order (ADO) to a destination in Poland. The contract mandates strict adherence to medical and hazardous material standards, requiring marking in accordance with Medical Marking Standard No. 1 and packaging per MIL-STD-2073-1E. Suppliers must provide Safety Data Sheets (SDS) and Hazardous Communication Standard labels prior to award, with a copy of the SDS accompanying each shipment. Invoicing must be processed through the Wide Area WorkFlow (WAWF) system. Key regulatory clauses include the Buy American Act, DFARS cybersecurity reporting requirements, and the prohibition of additive manufacturing processes for the provided items. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BUPIVACAINE HYDROCHLOR

Solicitation # SPE2DP-27-T-0203

Solicitation SPE2DP-27-T-0203, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Bupivacaine Hydrochloride Injection, USP, 0.5%, 50 ML. The requirement consists of two units under NSN 6505001387347, with a non-extendable shelf life of 24 months. The product is FDA-regulated and must be stored between 20 to 25 degrees Celsius. Delivery is required within five days of award, with an original required delivery date of October 30, 2026, shipped FOB Destination to the US Army SSA in Powidz, Poland. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical materials. Packaging must be commercial, utilizing sealed unit containers and exterior shipping containers compliant with MIL-STD-2073-1E and DLA packaging requirements for palletization. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and payment. The solicitation incorporates various FAR and DFARS clauses regarding hazardous material identification, cybersecurity reporting, and domestic origin preferences under the Buy American Act.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Atropine Autoinjector Manufacturing

POSTED

DEADLINE

Cell Separation and Processing Reagent Supplier

242-NETWORK Contract Office 02 (36C242)

POSTED

DEADLINE

Laboratory Quality Control (QC) Material Supplier

242-NETWORK Contract Office 02 (36C242)

POSTED

DEADLINE

Atropine Auto-Injector

Solicitation # SPE2DP-27-R-ATRO

DLA Troop Support is conducting market research via a sources sought notice for the procurement of Atropine Auto-Injectors under solicitation SPE2DP-27-ATRO. The agency intends to award a firm-fixed price, indefinite delivery, indefinite quantity contract consisting of a one-year base term and four one-year option terms. The required devices must deliver 1.67 mg of atropine base (equivalent to 2 mg atropine sulfate) and be 99.5 percent reliable, with a dispensing time of 0.5 seconds and an activation force between 0.90 and 3.60 kg. All products must be FDA approved per NDA No. 212319, comply with USP sterility standards, and maintain a minimum shelf life of 24 months upon delivery to DLA Distribution Susquehanna in New Cumberland, Pennsylvania. Strict packaging and marking requirements are mandated, including individual sealed polyethylene bags, intermediate boxes of 40 units, and exterior containers of 480 units, all conforming to MIL-STD-2073-1 and ASTM D4169-16. Labels must include specific dosage, storage, and usage instructions for nerve agent and insecticide poisoning. Interested respondents must provide their CAGE code, business size under NAICS 325412, and certification of commerciality per FAR 2.101. Manufacturers must submit FDA registration, while authorized distributors must provide a letter of commitment from the manufacturer. Responses are due by December 1, 2026.

POSTED

DEADLINE

Supply of Electrical Insulation Tape (NSN 5970-01-012-4280)This subcontract involves the supply of electrical insulation tape, identified by NSN 5970-01-012-4280, for prime contractors working on DLA Weapons Support ASC projects. The contractor is required to provide two rolls of tape delivered FOB Origin to Evenes Airbase. All materials must strictly conform to technical specification BASIC CID A-A-59474D, Revision D, and adhere to MIL-STD-2073-1E and RP001 for packaging and MIL-STD-129 for marking. To be eligible, the supplier must hold either SAE AS9003 or ISO 9001 certification and maintain full compliance with DFARS 252.204-7012. This procurement is managed by the Department of Defense under the DLA Weapons Support ASC Supplier Oper AE and AF Div, with a response deadline set for November 5, 2026.

DLA WEAPONS SUPPORT ASC SUPPLIER OPER AE AND AF DIV

POSTED

DEADLINE

Sterile X-Ray Detectable Packing Gauze SupplierThis subcontract involves the supply of 640 units of sterile, medical-grade packing gauze for prime contractors supporting Department of Defense medical supply contracts. The required product is a 1-ply, soft, white Z-fold gauze measuring 3 inches by 5 yards, featuring an embedded X-ray detectable line. To ensure clinical safety and longevity, the gauze must be sterilized to medical standards to maintain a shelf life of 60 months. The contract is managed under the Medical Supply Chain MD Surg FSF and requires strict adherence to the Berry Amendment and the Buy American Act for NSN 6510-01-695-5824. Performance for this requirement is centered in San Diego, California. Interested parties must note the response deadline of November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Tolnaftate Powder (USP 1%)This subcontract involves the supply of Tolnaftate Powder, USP 1%, to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The requirement specifies the delivery of two bottles of pharmaceutical product, with each unit consisting of a 45 GM sealed container. All supplies must strictly adhere to United States Pharmacopeia standards and utilize commercial packaging and packing methods to ensure the integrity of the contents. The opportunity is categorized under NAICS code 325412 and is associated with a performance location in FPO 96678. Interested parties must note the response deadline of November 3, 2026, following the posting date of October 28, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Disposable PVP Iodine ApplicatorsThis subcontract involves the supply of individually packaged disposable PVP Iodine swab sticks to prime contractors supporting Department of Defense medical supply contracts through DLA Troop Support. The required product must match NSN 6515-01-519-2226, utilizing medical-grade Povidone-Iodine solution and medical-grade packaging. Each delivery unit consists of packages containing 50 applicators. Strict quality and timing standards are mandated, requiring a minimum shelf life of 15 months and delivery within two months of the date of manufacture. The contract is categorized under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF. Performance for this requirement is designated for FPO 09592-4700.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

1 day ago

DEADLINE

in 5 days

AI Contract Overview

The contract calls for the delivery of 3 bulk units of Guaifenesin 600mg extended-release tablets, each containing 500 tablets, under solicitation SPE2DP-26-T-3451, with a mandatory delivery window of 20 days after award to Fort Bragg, North Carolina, under FOB Destination terms. The product must meet strict pharmaceutical standards, including a minimum 36-month shelf life from manufacture, with no less than 31 months remaining at the time of government receipt. Packaging must adhere to commercial specifications as defined in the procurement document, with each unit sealed in protective containers and shipped in durable exterior packaging suitable for safe transit via common carrier at the lowest possible rate, including export compliance when applicable. All markings must conform to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical items, and preservation and packing must comply with MIL-STD-2073-1E. The item is regulated by the FDA, and the contracting official must submit a referral to confirm manufacturer and product details prior to award. The supplier must be registered in the System for Award Management and comply with all applicable DLA Technical and Quality Requirements, including those identified by R and I numbers referenced in the DLA Master List. The contract incorporates a comprehensive set of Federal Acquisition Regulation clauses governing quality assurance, transportation, cybersecurity, labor compliance, sustainable procurement, and hazardous material handling, with multiple deviations and alternates applied, particularly around safeguarding, changes, subcontracting, and information systems protection. All invoices must be submitted electronically via Wide Area WorkFlow, and no alternative invoicing methods are permitted. Inspection and acceptance occur at the delivery point, with government personnel responsible for verifying compliance with packaging, labeling, and shelf-life requirements. The solicitation explicitly prohibits the use of covered defense telecommunications equipment from prohibited entities and requires offerors to disclose their entity identifier, CAGE code, and size status, including any applicable socioeconomic certifications. The contract is issued under the Department of Defense’s Medical Supply Chain, with Morgan Kelly identified as the primary point of contact, and all administrative data including payment details, appropriation codes, and contracting officer assignments will be finalized upon award. The acquisition is treated as a simplified purchase without a specified contract type or pricing, and no evaluation factors or weights are outlined for award determination.

General Info

Procure 600mg guaifenesin tablets, 3 bottles, deliver to Fort Bragg within 20 days.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

5234 EAGLE TALON DR BLDG X3063, FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

RFQ SPE2DP-26-T-3451 Medical Supply Chain

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedMay 18

Solicitation

Response DeadlineMay 26

Deadline has passed

Submission Closed

05/26/2026, 05:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUSA

Contacts

Morgan Kelly

contact@example.gov

+1 (555) 000-0000

Full Description

GUAIFENESIN EXTENDE
GUAIFENESIN EXTENDED-RELEASE TABLETS,600MG, 500S
U/I "BT" (500'S)
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL HAVE A SHELF LIFE OF 36 MONTHS.
NOT LESS THAN 31 MONTHS SHALL REMAIN FROM DATE OF MANUFACTURE TO DATE OF
DELIVERY TO THE GOVERNMENT.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
INCLUDE R2660 OBJECT TEXT ID ST
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
SPE2DP-26-T-3451
SECTION B
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
THE HARVARD DRUG GROUP, L.L.C. 1LEZ0 P/N NDC00904-6986-04 RECKITT BENCKISER LLC 0MWS8 P/N NDC63824-0008-50
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016814962 0001 BT 3.000
NSN/MATERIAL:6505013405446
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-340-5446 Quantity: 3 BT Purchase Request: 7016814962QTY: 3 Delivery: 20 days ADO